These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 10448113)
41. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease. Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485 [TBL] [Abstract][Full Text] [Related]
42. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China. Chen XF; Zhang HT; Qi QY; Sun MM; Tao LY Lung Cancer; 2005 Apr; 48(1):69-76. PubMed ID: 15777972 [TBL] [Abstract][Full Text] [Related]
43. Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression. Nuciforo PG; Luise C; Capra M; Pelosi G; d'Adda di Fagagna F Carcinogenesis; 2007 Oct; 28(10):2082-8. PubMed ID: 17522062 [TBL] [Abstract][Full Text] [Related]
44. Molecular mechanisms in Barrett's metaplasia and its progression. Izzo JG; Luthra R; Wu TT; Correa AM; Luthra M; Anandasabapathy S; Chao KS; Hung MC; Aggarwal B; Hittelman WN; Ajani JA Semin Oncol; 2007 Apr; 34(2 Suppl 1):S2-6. PubMed ID: 17449347 [TBL] [Abstract][Full Text] [Related]
45. [Tumor markers and genetic changes in lung cancer]. Dediu M Pneumologia; 1999; 48(4):317-20. PubMed ID: 10856995 [No Abstract] [Full Text] [Related]
46. Molecular changes track recurrence and progression of bronchial precancerous lesions. Sozzi G; Oggionni M; Alasio L; Conte D; Tavecchio L; Pilotti S; Spinelli P; Calarco G Lung Cancer; 2002 Sep; 37(3):267-70. PubMed ID: 12234694 [TBL] [Abstract][Full Text] [Related]
47. [Preneoplasias of the bronchial system. Pathologic anatomy]. Müller KM Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():644-8. PubMed ID: 6647306 [No Abstract] [Full Text] [Related]
48. [Preneoplasias of the bronchial system]. Maassen W Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():649-53. PubMed ID: 6647307 [No Abstract] [Full Text] [Related]
49. Early Events in the Molecular Pathogenesis of Lung Cancer. Kadara H; Scheet P; Wistuba II; Spira AE Cancer Prev Res (Phila); 2016 Jul; 9(7):518-27. PubMed ID: 27006378 [TBL] [Abstract][Full Text] [Related]
50. Genomic evidence of pre-invasive clonal expansion, dispersal and progression in bronchial dysplasia. McCaughan F; Pipinikas CP; Janes SM; George PJ; Rabbitts PH; Dear PH J Pathol; 2011 Jun; 224(2):153-9. PubMed ID: 21506132 [TBL] [Abstract][Full Text] [Related]
51. Molecular genetic changes found in human lung cancer and its precursor lesions. Gazdar AF; Bader S; Hung J; Kishimoto Y; Sekido Y; Sugio K; Virmani A; Fleming J; Carbone DP; Minna JD Cold Spring Harb Symp Quant Biol; 1994; 59():565-72. PubMed ID: 7587113 [No Abstract] [Full Text] [Related]
52. Early detection of central lung cancer: are we there yet? Musani AI; Al-Zubaidi A Respir Res; 2015 Apr; 16(1):53. PubMed ID: 25903458 [No Abstract] [Full Text] [Related]
53. [Feasibility of a cytologic method of evaluating the results of treating lung cancer]. Kliukina LB; Buglova SE; Kruglova NE Lab Delo; 1984; (4):206-9. PubMed ID: 6202937 [No Abstract] [Full Text] [Related]
54. Chemoprevention in lung cancer. Saba N; Jain S; Khuri F Curr Probl Cancer; 2004; 28(5):287-306. PubMed ID: 15375805 [No Abstract] [Full Text] [Related]
55. [Diagnosis and evaluation of lung cancer. Development during 1973-1982]. Robience YJ; Delwarte J; Libert P; Halloy JL; Richez M; Ravez P; Chattou O; Caliman P Rev Med Brux; 1986 Oct; 7(8):465-72. PubMed ID: 3797901 [No Abstract] [Full Text] [Related]